摘要:
Disclosed is a substrate and process for nucleic acid immobilization on a solid support. A polyanion containing an activated ester is covalently attached to a solid support. In one preferred embodiment, the polyanion is polyacrylic acid.
摘要:
A convenient and effective method for amplifying a nucleic acid sequence characterized by effecting a DNA synthesis reaction in the presence of chimeric oligonucleotide primers; a method for supplying a large amount of DNA amplification fragments; an effective method for amplifying a nucleic acid sequence by combining the above method with another nucleic acid sequence amplification method; a method for detecting a nucleic acid sequence for detecting or quantitating a microorganism such as a virus, a bacterium, a fungus or a yeast; and a method for detecting a DNA amplification fragment obtained by the above method in situ.
摘要:
Compounds represented by general formula (I) wherein X represents OH or OSO 3 H; and R represents a substituent other than OH which allows, after leaving, the induction of unsaturated bonds into the 3- and 4-positions of 3,6-anhydrogalactose or its sulfated derivative, and/or a substituent showing a tissue-specific affinity.
摘要:
Polypeptides having the amino acid sequence represented by SEQ ID NO:1 or derived therefrom by at least one of deletion, addition, insertion or substitution of one or more amino acids in the above sequence and showing a cellobiohydrolase activity.
摘要翻译:具有由SEQ ID NO:1表示的氨基酸序列或通过上述序列中的一个或多个氨基酸的缺失,添加,插入或取代中的至少一种而显示出纤维二糖水解酶活性的多肽。
摘要:
A method for immobilizing an oligonucleotide on a carrier by spotting a buffer containing the oligonucleotide onto the carrier, characterized in that the oligonucleotide is immobilized on the carrier via a covalent bond.
摘要:
Remedies or preventives for diseases with a need for immunoregulation, diseases with a need for inhibition of inflammation, diseases with a need for regulation of tumor necrosis factor production, diseases with a need for regulation of fungal growth, diseases with a need for regulation of cell adhesion or disease with a deed for induction of heat-shock protein, which contain as the active ingredient at least one compound selected from among cyclopentenone derivatives represented by general formula [I], optically active isomers and salts thereof, wherein R 1 and R 2 are the same or different and each represents hydrogen, an aliphatic group, an aromatic group or an aromatic aliphatic group.
摘要:
A DNA synthesis method with a shortened time period required for DNA synthesis by polymerase chain reaction (PCR), characterized in that a DNA polymerase is used in an amount effective for providing more than 10 ng of amplified DNA fragments of about 2 kb per 50 µl of a reaction mixture, when PCR is carried out under the following conditions (A) and (B): (A) reaction mixture: 50 µl volume of a reaction mixture comprising DNA polymerase, 1 ng of genomic DNA from Escherichia coli, and 10 pmol each of primers Eco-1 and Eco-2 (nucleotide sequences of the primers Eco-1 and Eco-2 being shown in SEQ ID NOs: 10 and 11 of Sequence Listing, respectively); and having a composition suitable for the DNA polymerase; and (B) reaction conditions: 35 cycles of PCR, wherein one cycle consists of 99°C, 1 second - 66°C, 7 seconds; a kit for DNA synthesis usable for the DNA synthesis method; and an article of manufacture of a PCR agent. According to the present invention, the procedures in the genetic engineering studies and industries involved with PCR can be speeded up.
摘要翻译:一种通过聚合酶链式反应(PCR)进行DNA合成所需的时间缩短的DNA合成方法,其特征在于使用DNA聚合酶,其用量可提供超过10ng的扩增DNA片段,每50ul约2kb (A)和(B):(A)反应混合物:50μl体积的包含DNA聚合酶的反应混合物,1ng来自大肠杆菌的基因组DNA, 和引物Eco-1和Eco-2(引物Eco-1和Eco-2的核苷酸序列分别示于序列表的SEQ ID NO:10和11中)的10pmol; 并具有适合于DNA聚合酶的组合物; 和(B)反应条件:35个循环的PCR,其中一个循环由99℃,1秒-66℃,7秒; 用于DNA合成方法的DNA合成试剂盒; 和PCR试剂的制造。 根据本发明,可以加快基因工程研究中涉及PCR的工艺步骤。
摘要:
The invention describes a DNA having a sequence encoding a polypeptide possessing endoglycoceramidase activator activity or functionally equivalent variants thereof; and a method for producing a polypeptide possessing endoglycoceramidase activator activity or functionally equivalent variants thereof by gene recombinant technology.
摘要:
Apoptosis inducers represented by chemical formulae (I), (II), (VIII), (IV), (V), (VI), (III) and (VII); and medicinal compositions containing the same and usable as carcinostatic and the like.